Sequent Scientific Ltd.
NSE: SEQUENT | BSE: 512529
₹244.50
₹-2.85
(-1.15%)
As on 17-Jun-2026 14:59IST
Market cap
₹10,826 Cr
Revenue (TTM)
₹2,644 Cr
P/E Ratio
61.1
P/B Ratio
3.7
Div. Yield
0 %
Quality Score
1/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹120 Cr
-
ROE
5.4 %
-
ROCE
9.3 %
-
Industry P/E
37.64
-
EV/EBITDA
15.8
-
Debt to Equity
0.1
-
Book Value
₹66.6
-
EPS
₹3.8
-
Face value
2
-
Shares outstanding
436,875,477
10 Years Aggregate
CFO
₹545.46 Cr
EBITDA
₹1,027.91 Cr
Net Profit
₹147.17 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sequent Scientific
| 17.2 | 8.9 | 25.6 | 23.3 | 47.7 | -2.0 | 8.0 |
|
BSE Healthcare
| 8.4 | -0.3 | 11.2 | 6.5 | 23.4 | 13.3 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Sequent Scientific
| 12.9 | 52.7 | 29.9 | -45.6 | -5.3 | 139.1 | 4.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sequent Scientific
|
244.5 | 10,825.8 | 2,643.8 | 152.1 | 12.0 | 7.7 | 61.1 | 3.7 |
| 2,986.3 | 24,527.8 | 1,339.4 | 356.4 | 33.2 | 23.2 | 68.8 | 14.8 | |
| 3,086.7 | 38,405.2 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.4 | 8.5 | |
| 1,713.1 | 32,527.6 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.2 | 6.6 | |
| 2,056.1 | 1,750.6 | 332.6 | 51.1 | 20.4 | 15.4 | 31.5 | 4.9 | |
| 2,198.4 | 35,094.9 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.5 | 8.4 | |
| 16,985.0 | 21,695.3 | 2,023.0 | 364.0 | 23.9 | 20.8 | 59.6 | 11.6 | |
| 2,946.1 | 1,845.2 | 501.2 | 48.0 | 10.4 | 15.3 | 38.3 | 5.6 | |
| 163.5 | 21,800.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 2,030.0 | 33,195.5 | 3,373.0 | 199.0 | 12.6 | 5.9 | 155.8 | 6.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sequent Scientific
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
1985
-
Chairman
Kamal K Sharma
-
Managing Director
Rajaram Narayanan
-
Group
Sequent
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Sequent Scientific Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Sequent Scientific
What is the current share price of Sequent Scientific Ltd Today?
The share price of Sequent Scientific Ltd is ₹244.50 (NSE) and ₹244.10 (BSE) as of 17-Jun-2026 14:59 IST. Sequent Scientific Ltd has given a return of 47.69% in the last 3 years.
What is the current PB & PE ratio of Sequent Scientific Ltd?
The P/E ratio of Sequent Scientific Ltd is 61.07 times as on 17-Jun-2026, a 62 premium to its peers’ median range of 37.64 times.
The P/B ratio of Sequent Scientific Ltd is 3.72 times as on 17-Jun-2026, a 28 discount to its peers’ median range of 5.17 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
149.64
|
5.39
|
|
2024
|
0.00
|
4.96
|
|
2023
|
0.00
|
2.82
|
|
2022
|
81.14
|
5.15
|
|
2021
|
62.69
|
8.31
|
What is the 52 Week High and Low of Sequent Scientific Ltd?
The 52-week high and low of Sequent Scientific Ltd are Rs 277.35 and Rs 166.00 as of 17-Jun-2026.
What is the market cap of Sequent Scientific Ltd?
Sequent Scientific Ltd has a market capitalisation of ₹ 10,826 Cr as on 17-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sequent Scientific Ltd?
Before investing in Sequent Scientific Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.